preview diverg oper trend celltrion hc remain beneficiari
new product cycl
celltrion inc cti like releas mid-may
forecast op downsid bn opm vs bbg
bn opm given prolong outsourc cost remsima iv
on-going product changeov pco pressur
celltrion hc cthc seem track well subsequ new
launch us/eu regional/product diversif fuel
op bn vs bbg bn us truxima/inflectra uptak
moder late competit risk remain pfizer/amgen
expect cthc out-performance cti trade
premium view trend could persist throughout year
cti manufactur pressur due increas product
portfolio cti antibodi program view
conjunct valuat methodolog revis set new
tp cti
maintain
under-perform ep fine tune cthc tp hike
remain neutral given recent ralli
revis cthc ep stronger trend
anoth soft celltrion inc celltrion inc cti
like releas mid-may think street optimist
quarterli op downsid bn opm vs bbg
bn opm given prolong outsourc cost remsima
iv lonza cti outsourc cost biosimilar divis
parent entiti jump bn qoq attribut major
explain lonza cost addit cti
disclos product four in-hous product
neg impact margin due on-going product
gpm contract outsourc cost
translat higher margin
trend provid colour inflectra price eros
expect broadli limit impact howev
still forese near-term risk us truxima/inflectra uptak
moder late competit risk remain pfizer/amgen
figur cthc region expans
eu remsima sc
disagre recent theme-driven ralli expect cthc
out-performance cti near-term trade valuat
premium view trend could persist throughout year
cti
manufactur pressur due increas product
portfolio increas product portfolio must compani deliv
growth appli cti tight product
scheme besid cti antibodi program
view public health perspect given limit commerci outlook
launch truxima inflectra
uptak moder late
cthc still trade premium cti
solid trend celltrion hc celltrion hc cthc seem track
well thank subsequ new launch us herzuma
eu remsima sc regional/product diversif fuel
op bn vs bbg bn given higher margin profil
may need cross check partner competitor
new tp base new valuat methodolog
unchang conjunct valuat methodolog revis
set new tp cti maintain
under-perform ep fine tune factor
increas cost program cthc tp hike
remain neutral given recent ralli
theme revis ep stronger trend
tp
statu non-u analyst us disclosur credit suiss seek busi compani cover research report result investor
awar firm may conflict interest could affect object report investor consid report singl factor make invest
charl martineau pm univers toronto compani mention price
ray certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view express
report
price rate histori celltrion healthcar co ltd
signifi initi assumpt coverag
price rate histori celltrion inc
signifi initi assumpt coverag
decemb analyst stock rate defin follow
outperform stock total return expect outperform relev benchmark next month
neutral stock total return expect line relev benchmark next month
under-perform stock total return expect under-perform relev benchmark next month
relev benchmark region decemb japanes rate base stock total return rel analyst
coverag univers consist compani cover analyst within relev sector outperform repres
attract neutral less attract underperform least attract invest opportun octob
canadian well european exclud turkey rate base stock total return rel analyst coverag univers
consist compani cover analyst within relev sector outperform repres attract neutral less
attract underperform least attract invest opportun latin america turkey asia exclud japan australia
stock rate base stock total return rel averag total return relev countri region benchmark india
bse sensex index prior octob canadian rate base stock absolut total return potenti
current share price rel attract stock total return potenti within analyst coverag univers australian
charl martineau pm univers toronto new zealand stock expect total return calcul includ roll dividend yield outperform rate assign
greater equal under-perform less equal neutral may assign
overlap rate rang allow analyst assign rate put context associ risk
prior may rang outperform under-perform rate overlap neutral threshold
oper juli
restrict certain circumst credit suiss polici and/or applic law regul preclud certain type commun
includ invest recommend cours credit suiss engag invest bank transact certain
circumst
rate nr credit suiss equiti research invest rate view stock secur relat
compani time
cover nc credit suiss equiti research provid on-going coverag compani offer invest rate
invest view equiti secur compani relat product
volatil indic stock defin volatil stock price move month least
past month analyst expect signific volatil go forward
analyst sector weight distinct analyst stock rate base analyst expect fundament and/or
valuat sector rel group histor fundament and/or valuat
overweight analyst expect sector fundament and/or valuat favor next month
market weight analyst expect sector fundament and/or valuat neutral next month
underweight analyst expect sector fundament and/or valuat cautiou next month
analyst coverag sector consist compani cover analyst within relev sector analyst may cover multipl sector
credit suiss distribut stock rate bank client
purpos nyse finra rate distribut disclosur requir stock rate outperform neutral under-perform
